Prescription Drug Price Transparency
- Prescription Drug Price Transparency Home
- Reporting Resources
- Drugs of Substantial Public Interest Lists
- Research and Analysis
- Data and Dashboards
- Publications
- For Reporting Entities
Related Sites
Prescription Drug Price Transparency
Publications
Legislative Reports
Reports to the legislature—required under the Prescription Drug Price Transparency Act (Minnesota Statutes 62J.84)—present summaries and analysis of data reported to MDH and assess the Act’s progress toward statutory goals.
Last Updated: 11/05/2025